[Event Report] Roundtable – The Increasing Role of Japanese Pharmaceutical Companies in Global Health (December 11, 2018)
date : 1/7/2019
Tags: Global Health, Other activities
![[Event Report] Roundtable – The Increasing Role of Japanese Pharmaceutical Companies in Global Health (December 11, 2018)](https://hgpi.org/en/wp-content/uploads/sites/2/PC110232-1.jpg)
HGPI convened a roundtable on “The Increasing Role of Japanese Pharmaceutical Companies in Global Health.” This meeting was held in accordance with online publication of “Access to Medicine Index 2018” by the Access to Medicine Foundation (published on November 20, 2018).
The roundtable was jointly hosted by the Access to Medicine Foundation, the Health and Global Policy Institute (HGPI), and the Japan International Cooperation Agency (JICA). Support was also provided by the Japanese Ministry of Foreign Affairs (MOFA).
■Seminar Overview
Date and Time:Tuesday, December 11, 2018 08:30 to 10:30
Venue :Grand Cube 3F, Otemachi Financial City, Global Business Hub Tokyo
Program:
08:30-08:35 Opening Remarks
Yasuhiro Suzuki(Chief Medical and Global Health Officer and Vice-Minister for Health, Ministry of Health, Labour and Welfare of Japan)
08:35-09:00 Access to Medicine Index 2018: Key Findings
Danny Edwards(Research Program Manager, Access to Medicine Foundation)
09:00-09:30 Q&A
09:30-09:40 Discussants: Building on the results of the 2018 Access to Medicine Index
Sumi Manabu(Director, Global Health Policy Division, International Cooperation Bureau, Ministry of Foreign Affairs of Japan)
Ritsuko Yamagata(Director, Health Team 2, Human Development Department, Japan International Cooperation Agency)
09:40-10:25 Discussion
10:25-10:30 Closing Remarks
Damiano de Felice(Director of Strategy, Access to Medicine Foundation)
日本語
Top Research & Recommendations Posts
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Policy Recommendations] Establishing an Integrated Care System for Pain from the Perspectives of People with Lived Experience (March 29, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Announcement] Participation in an International Survey on Brain Health for Young People “The Next Generation (NextGen) Brain Health Research Program” (July 1, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Japanese Version Release] “Call for Actionable Steps in Response to the Rising Threat of Antimicrobial Resistance (AMR)” (July 3, 2024)
Featured Posts
-
2024-07-01
[Registration Open] Meaningful Involvement Promotion Project Online Expert Meeting “Shaping the Future of Health Policy with People with Lived Experience and Citizens” (July 26, 2024)
-
2024-07-17
[Event Report] Non-partisan Diet Member Briefing – 30-minute Health Policy Update: “Towards Overcoming Kidney Disease: Strengthening Measures Against CKD” (June 7, 2024)
-
2024-07-18
[Registration Open] (Hybrid Format) Kidney Disease Control Promotion Project Public Symposium “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” (August 28, 2024)
-
2024-07-22
[HGPI Policy Column] No. 44 — From the Planetary Health Policy Project, Part 9 “Connecting Climate Minds: the Intersection of Climate Change and Mental Health”
-
2024-07-23
[Registration Open] (Webinar) HGPI Special Seminar “The Emerging Threat of Antifungal Resistance — Considering Infectious Diseases Caused by Mold and Measures to Combat Drug Resistance” (August 23, 2024)